ArticleScientific reports2024

Selection of anti-cytokine biologics by pretreatment levels of serum leucine-rich alpha-2 glycoprotein in patients with inflammatory bowel disease.

Takahiro Amano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.